Group Finance Director and Company Secretary
Kirsten Lund was promoted to the position of Group Finance Director in November 2019 after being Group Financial Controller for over a year. Kirsten leads the finance teams in both the UK and US, and advises the Board on all financial matters relating to the Group.
After joining Tissue Regenix in 2010 as Finance and Administration Assistant, Kirsten successfully completed the ACCA qualification, achieving chartered status in 2015. Kirsten has been a key member of the team throughout the last 10 years. Utilising the knowledge acquired over the years in the healthcare sector, Kirsten provides invaluable experience and understanding around the Company structure and routes to market, and works closely with the management team to help drive forward the strategy of the business.